Design of a New Hydrazine Moiety-Based Near-Infrared Fluorescence Probe for Detection and Imaging of Endogenous Formaldehyde In Vivo.
Ning DingZhao LiYitong HaoChengxiao ZhangPublished in: Analytical chemistry (2022)
Formaldehyde (FA), the smallest molecular aldehyde with strong reducing properties, could regulate body homeostasis endogenously during physiological and pathological processes. The effective near-infrared (NIR) fluorescent probe is needed as a visualizer of FA in biologic organisms. In this work, a novel NIR fluorescent Probe - NHNH 2 was designed on the basis of Probe - NH 2 via introducing a strong nucleophilic hydrazine group, which can be used as a quenching and recognizing moiety for the detection of FA. With the treatment of FA, the hydrazine group of Probe - NHNH 2 undergoes condensation and achieves a turn-on NIR fluorescence signal at a wavelength of 706 nm. The spectroscopic performance of Probe-NHNH 2 for FA was evaluated, and it exhibited high sensitivity and selectivity for the detection of FA in solution. Moreover, compared to the amine moiety-based Probe - NH 2, which our group reported, we found that hydrazine moiety-based Probe - NHNH 2 , exhibited a better reaction time of within 10 min and a lower detection limit of 0.68 μM, reflecting that the reaction of FA with hydrazine moiety is faster and more sensitive than that of FA with the amino group. More importantly, Probe - NHNH 2 was successfully applied to real-time imaging of endogenous FA by reacting with effective stimulant tetrahydrofolate and scavenger sodium bisulfite in zebrafish and mice. It is expected that we can provide a new rapid, sensitive NIR fluorescence theoretical basis for FA detection and in vivo imaging applications.
Keyphrases
- fluorescent probe
- living cells
- loop mediated isothermal amplification
- high resolution
- single molecule
- label free
- real time pcr
- room temperature
- rheumatoid arthritis
- type diabetes
- attention deficit hyperactivity disorder
- photodynamic therapy
- quantum dots
- drug delivery
- adipose tissue
- metabolic syndrome
- multidrug resistant
- skeletal muscle
- combination therapy
- structural basis